mHealth Technologies to Enhance PrEP Adherence Among Thai MSM

NCT04413708 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-03-12

Study results available
· View outcomes & findings →

Summary

This study aims to: 1) adapt the theory-based P3 (Prepared, Protected, emPowered) app designed to improve pre-exposure prophylaxis (PrEP) adherence, retention in PrEP clinical care, and PrEP persistence among young gay, bisexual, and other men who have sex with men (YMSM) in the United States for YMSM in Thailand, and 2) conduct a pilot randomized controlled trial (RCT) to assess the feasibility, acceptability, and potential impact of the adapted P3-Thailand (P3-T) app.

Conditions

  • Adherence, Patient
  • Pre-Exposure Prophylaxis
  • HIV/AIDS

Interventions

BEHAVIORAL

P3-T PrEP Adherence App

P3-T provides daily PrEP reminders, a medication tracker and calendar, personalized medication adherence strategies, refill reminders, and tailored adherence support messages; social support via a social wall that includes daily discussion prompts; daily quests to build knowledge and skills; a multimedia knowledge center; interactive narrative collections; personalized adherence counseling provided by an adherence counselor via in-app messaging; in-app rewards; a "bank account" that rewards daily app use by adding or subtracting a small financial reward based on daily app use; and, a user profile that includes a user-selected avatar.

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    collaborator OTHER
  • Chulalongkorn University

    collaborator OTHER
  • Thai Red Cross AIDS Research Centre

    collaborator OTHER
  • Fogarty International Center of the National Institute of Health

    collaborator NIH
  • Duke University

    lead OTHER

Principal Investigators

  • Sara LeGrand, Ph.D. · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
24 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-12
Primary Completion
2021-08-10
Completion
2021-08-10

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04413708 on ClinicalTrials.gov